Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Fusion | 13 | 2025 | 114 | 5.380 |
Why?
|
| Spinal Cord Injuries | 8 | 2020 | 287 | 2.120 |
Why?
|
| Cervical Vertebrae | 8 | 2025 | 117 | 1.760 |
Why?
|
| Atlanto-Axial Joint | 3 | 2021 | 22 | 1.450 |
Why?
|
| Spinal Diseases | 2 | 2021 | 46 | 1.390 |
Why?
|
| Pedicle Screws | 2 | 2022 | 3 | 1.390 |
Why?
|
| Intervertebral Disc Displacement | 3 | 2025 | 19 | 1.370 |
Why?
|
| Bone Transplantation | 5 | 2021 | 50 | 1.290 |
Why?
|
| Lumbar Vertebrae | 6 | 2025 | 113 | 1.190 |
Why?
|
| Spinal Cord Compression | 3 | 2017 | 33 | 1.080 |
Why?
|
| Intervertebral Disc Degeneration | 5 | 2018 | 17 | 1.070 |
Why?
|
| Central Nervous System Vascular Malformations | 2 | 2021 | 17 | 1.060 |
Why?
|
| Spinal Cord Diseases | 2 | 2021 | 35 | 1.050 |
Why?
|
| Surgical Wound Infection | 2 | 2022 | 272 | 0.940 |
Why?
|
| Laminectomy | 4 | 2020 | 24 | 0.930 |
Why?
|
| Diskectomy | 1 | 2025 | 13 | 0.920 |
Why?
|
| Embolization, Therapeutic | 2 | 2021 | 223 | 0.900 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2022 | 68 | 0.890 |
Why?
|
| Thoracic Vertebrae | 7 | 2025 | 69 | 0.860 |
Why?
|
| Spinal Neoplasms | 3 | 2025 | 75 | 0.850 |
Why?
|
| Occipital Bone | 3 | 2021 | 21 | 0.830 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2025 | 2166 | 0.810 |
Why?
|
| Neck Pain | 1 | 2022 | 19 | 0.780 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2019 | 87 | 0.760 |
Why?
|
| Spinal Cord Neoplasms | 3 | 2019 | 72 | 0.750 |
Why?
|
| Physical Examination | 1 | 2022 | 165 | 0.720 |
Why?
|
| Kyphosis | 1 | 2021 | 22 | 0.700 |
Why?
|
| Surgical Flaps | 2 | 2022 | 189 | 0.690 |
Why?
|
| Radiation Injuries | 1 | 2021 | 158 | 0.640 |
Why?
|
| Meningocele | 1 | 2019 | 18 | 0.630 |
Why?
|
| Postoperative Complications | 8 | 2019 | 3139 | 0.620 |
Why?
|
| Pseudarthrosis | 1 | 2019 | 6 | 0.620 |
Why?
|
| Spondylolisthesis | 1 | 2018 | 6 | 0.590 |
Why?
|
| Neuronavigation | 1 | 2018 | 10 | 0.590 |
Why?
|
| Neural Stem Cells | 2 | 2016 | 149 | 0.560 |
Why?
|
| Stem Cell Transplantation | 2 | 2016 | 249 | 0.540 |
Why?
|
| Epidural Abscess | 1 | 2017 | 12 | 0.530 |
Why?
|
| Tissue Scaffolds | 4 | 2019 | 78 | 0.530 |
Why?
|
| Meningomyelocele | 1 | 2019 | 253 | 0.500 |
Why?
|
| Humans | 53 | 2025 | 131924 | 0.490 |
Why?
|
| Spinal Fractures | 3 | 2025 | 47 | 0.480 |
Why?
|
| Disease Management | 2 | 2021 | 562 | 0.480 |
Why?
|
| Spinal Cord | 3 | 2018 | 267 | 0.480 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 620 | 0.470 |
Why?
|
| Neurosurgical Procedures | 5 | 2022 | 314 | 0.430 |
Why?
|
| Fractures, Compression | 3 | 2025 | 12 | 0.400 |
Why?
|
| Genetic Therapy | 2 | 2016 | 719 | 0.380 |
Why?
|
| Angiography | 1 | 2012 | 208 | 0.370 |
Why?
|
| Decompressive Craniectomy | 1 | 2011 | 15 | 0.370 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2012 | 126 | 0.360 |
Why?
|
| Corynebacterium Infections | 1 | 2011 | 5 | 0.360 |
Why?
|
| Body Fluids | 1 | 2011 | 47 | 0.360 |
Why?
|
| Glioma | 1 | 2016 | 529 | 0.360 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2012 | 227 | 0.350 |
Why?
|
| Drainage | 1 | 2012 | 262 | 0.350 |
Why?
|
| Klippel-Feil Syndrome | 2 | 2020 | 8 | 0.340 |
Why?
|
| Radiation Dosage | 1 | 2011 | 146 | 0.330 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2018 | 2850 | 0.330 |
Why?
|
| Ossification of Posterior Longitudinal Ligament | 3 | 2016 | 3 | 0.330 |
Why?
|
| Female | 32 | 2025 | 70584 | 0.330 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 376 | 0.320 |
Why?
|
| Abscess | 1 | 2011 | 139 | 0.320 |
Why?
|
| Low Back Pain | 2 | 2022 | 40 | 0.320 |
Why?
|
| Brain Ischemia | 2 | 2012 | 278 | 0.320 |
Why?
|
| Occupational Exposure | 1 | 2011 | 131 | 0.320 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2011 | 194 | 0.310 |
Why?
|
| Spine | 2 | 2021 | 147 | 0.290 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2019 | 1221 | 0.280 |
Why?
|
| Osteoporotic Fractures | 2 | 2018 | 30 | 0.270 |
Why?
|
| Absorbable Implants | 2 | 2018 | 26 | 0.270 |
Why?
|
| Male | 26 | 2025 | 64870 | 0.270 |
Why?
|
| Adult | 19 | 2025 | 31536 | 0.270 |
Why?
|
| Middle Aged | 19 | 2025 | 28943 | 0.260 |
Why?
|
| Aged | 13 | 2025 | 21385 | 0.260 |
Why?
|
| Hindlimb | 2 | 2017 | 76 | 0.240 |
Why?
|
| Acute Disease | 3 | 2025 | 1160 | 0.240 |
Why?
|
| Retrospective Studies | 9 | 2025 | 17374 | 0.230 |
Why?
|
| Spinal Injuries | 1 | 2025 | 33 | 0.230 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 4680 | 0.220 |
Why?
|
| Stroke | 2 | 2012 | 1083 | 0.220 |
Why?
|
| Physicians | 1 | 2011 | 641 | 0.210 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2017 | 3351 | 0.210 |
Why?
|
| Transplantation, Autologous | 2 | 2021 | 286 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2025 | 3829 | 0.200 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2025 | 221 | 0.200 |
Why?
|
| Rats | 4 | 2019 | 3608 | 0.190 |
Why?
|
| Diagnosis, Differential | 3 | 2022 | 1949 | 0.190 |
Why?
|
| Joint Instability | 2 | 2020 | 59 | 0.190 |
Why?
|
| Hydrocephalus | 2 | 2017 | 277 | 0.180 |
Why?
|
| Lordosis | 1 | 2021 | 7 | 0.180 |
Why?
|
| Foramen Magnum | 1 | 2021 | 5 | 0.180 |
Why?
|
| Neurosurgery | 1 | 2022 | 82 | 0.180 |
Why?
|
| Scapula | 1 | 2021 | 15 | 0.180 |
Why?
|
| Ilium | 1 | 2021 | 22 | 0.180 |
Why?
|
| Cadaver | 1 | 2021 | 119 | 0.170 |
Why?
|
| Ribs | 1 | 2021 | 54 | 0.170 |
Why?
|
| Spinal Stenosis | 1 | 2020 | 10 | 0.170 |
Why?
|
| Decompression, Surgical | 3 | 2020 | 91 | 0.160 |
Why?
|
| MicroRNAs | 2 | 2017 | 916 | 0.160 |
Why?
|
| Prospective Studies | 2 | 2022 | 6569 | 0.160 |
Why?
|
| Subdural Effusion | 1 | 2019 | 8 | 0.160 |
Why?
|
| Polymorphism, Genetic | 2 | 2013 | 803 | 0.150 |
Why?
|
| Coculture Techniques | 2 | 2017 | 234 | 0.150 |
Why?
|
| Contusions | 1 | 2018 | 16 | 0.150 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 1 | 2018 | 15 | 0.150 |
Why?
|
| Therapeutic Irrigation | 1 | 2018 | 45 | 0.150 |
Why?
|
| Thymidylate Synthase | 1 | 2018 | 21 | 0.140 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2018 | 31 | 0.140 |
Why?
|
| Arachnoid Cysts | 1 | 2017 | 7 | 0.140 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2018 | 64 | 0.140 |
Why?
|
| Dura Mater | 1 | 2017 | 25 | 0.140 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2017 | 14 | 0.130 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2017 | 20 | 0.130 |
Why?
|
| Third Ventricle | 1 | 2017 | 31 | 0.130 |
Why?
|
| Animals | 8 | 2019 | 34781 | 0.130 |
Why?
|
| Hemangioma, Cavernous | 1 | 2017 | 20 | 0.130 |
Why?
|
| Polyglycolic Acid | 1 | 2017 | 23 | 0.130 |
Why?
|
| Trauma Severity Indices | 1 | 2017 | 90 | 0.130 |
Why?
|
| Craniotomy | 2 | 2020 | 107 | 0.130 |
Why?
|
| Flucytosine | 1 | 2016 | 17 | 0.130 |
Why?
|
| Chondrosarcoma | 1 | 2016 | 13 | 0.130 |
Why?
|
| Ganglia, Spinal | 1 | 2017 | 69 | 0.130 |
Why?
|
| Cytosine Deaminase | 1 | 2016 | 21 | 0.130 |
Why?
|
| Hyaluronic Acid | 1 | 2017 | 108 | 0.130 |
Why?
|
| Locomotion | 1 | 2017 | 61 | 0.130 |
Why?
|
| Neuroimaging | 1 | 2020 | 376 | 0.130 |
Why?
|
| Thymidine Kinase | 1 | 2016 | 90 | 0.130 |
Why?
|
| Osteotomy | 1 | 2016 | 42 | 0.130 |
Why?
|
| Ganciclovir | 1 | 2016 | 101 | 0.130 |
Why?
|
| Lactic Acid | 1 | 2017 | 153 | 0.120 |
Why?
|
| Fluorouracil | 1 | 2016 | 138 | 0.120 |
Why?
|
| Scoliosis | 1 | 2017 | 143 | 0.120 |
Why?
|
| Spinal Dysraphism | 1 | 2019 | 274 | 0.120 |
Why?
|
| Reoperation | 1 | 2019 | 851 | 0.120 |
Why?
|
| Genetic Engineering | 1 | 2016 | 164 | 0.120 |
Why?
|
| Reflex | 1 | 2015 | 34 | 0.120 |
Why?
|
| Total Disc Replacement | 1 | 2015 | 2 | 0.120 |
Why?
|
| Cervical Cord | 1 | 2015 | 10 | 0.120 |
Why?
|
| Joint Prosthesis | 1 | 2015 | 18 | 0.110 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 306 | 0.110 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2015 | 57 | 0.110 |
Why?
|
| Recovery of Function | 1 | 2017 | 461 | 0.110 |
Why?
|
| Myelin Sheath | 1 | 2015 | 125 | 0.110 |
Why?
|
| Random Allocation | 1 | 2015 | 430 | 0.110 |
Why?
|
| Cranial Sutures | 1 | 2014 | 33 | 0.110 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 182 | 0.110 |
Why?
|
| Republic of Korea | 4 | 2016 | 53 | 0.110 |
Why?
|
| Case-Control Studies | 6 | 2018 | 3409 | 0.100 |
Why?
|
| Population | 1 | 2013 | 23 | 0.100 |
Why?
|
| Vitamin K Epoxide Reductases | 1 | 2013 | 7 | 0.100 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 258 | 0.100 |
Why?
|
| Radiography | 2 | 2015 | 819 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2015 | 1011 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 990 | 0.100 |
Why?
|
| Blood Patch, Epidural | 1 | 2012 | 6 | 0.100 |
Why?
|
| Intracranial Hypotension | 1 | 2012 | 12 | 0.100 |
Why?
|
| Sesquiterpenes | 1 | 2013 | 26 | 0.100 |
Why?
|
| Alkaloids | 1 | 2013 | 37 | 0.100 |
Why?
|
| Skull | 1 | 2014 | 143 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2013 | 192 | 0.100 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2012 | 33 | 0.090 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 133 | 0.090 |
Why?
|
| Sclerosis | 1 | 2012 | 31 | 0.090 |
Why?
|
| Fecal Incontinence | 1 | 2012 | 78 | 0.090 |
Why?
|
| Urinary Incontinence | 1 | 2012 | 78 | 0.090 |
Why?
|
| Endoscopy | 1 | 2014 | 288 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2012 | 62 | 0.090 |
Why?
|
| Craniosynostoses | 1 | 2014 | 130 | 0.090 |
Why?
|
| Brain Infarction | 1 | 2012 | 30 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2022 | 1247 | 0.090 |
Why?
|
| Moyamoya Disease | 1 | 2012 | 42 | 0.090 |
Why?
|
| Melanoma | 1 | 2019 | 950 | 0.090 |
Why?
|
| Cerebrovascular Disorders | 1 | 2012 | 118 | 0.090 |
Why?
|
| Radiosurgery | 1 | 2012 | 147 | 0.090 |
Why?
|
| Fluoroscopy | 1 | 2011 | 99 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 443 | 0.080 |
Why?
|
| Prognosis | 1 | 2020 | 5007 | 0.080 |
Why?
|
| Pain | 1 | 2013 | 457 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 7097 | 0.080 |
Why?
|
| Genotype | 4 | 2017 | 2696 | 0.070 |
Why?
|
| Back Pain | 2 | 2022 | 31 | 0.070 |
Why?
|
| Treatment Outcome | 8 | 2017 | 12991 | 0.070 |
Why?
|
| Time Factors | 2 | 2015 | 6440 | 0.070 |
Why?
|
| Inflammation | 1 | 2015 | 1519 | 0.070 |
Why?
|
| Follow-Up Studies | 4 | 2017 | 5408 | 0.060 |
Why?
|
| Pain Measurement | 2 | 2017 | 355 | 0.060 |
Why?
|
| Haplotypes | 2 | 2016 | 544 | 0.050 |
Why?
|
| Gene Frequency | 2 | 2016 | 749 | 0.050 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2022 | 84 | 0.050 |
Why?
|
| Machine Learning | 1 | 2025 | 345 | 0.040 |
Why?
|
| Workload | 1 | 2022 | 151 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2025 | 662 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2025 | 777 | 0.040 |
Why?
|
| Atlanto-Occipital Joint | 1 | 2020 | 6 | 0.040 |
Why?
|
| Odontoid Process | 1 | 2020 | 10 | 0.040 |
Why?
|
| Young Adult | 4 | 2017 | 9952 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 305 | 0.040 |
Why?
|
| Alleles | 2 | 2016 | 1684 | 0.040 |
Why?
|
| Bone Wires | 1 | 2019 | 7 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 438 | 0.040 |
Why?
|
| Bone Screws | 1 | 2019 | 53 | 0.040 |
Why?
|
| Disease Progression | 1 | 2025 | 2221 | 0.040 |
Why?
|
| Cell Differentiation | 2 | 2017 | 1960 | 0.040 |
Why?
|
| Polyesters | 1 | 2018 | 41 | 0.040 |
Why?
|
| Polyradiculopathy | 1 | 2017 | 2 | 0.040 |
Why?
|
| Lysine | 1 | 2018 | 185 | 0.030 |
Why?
|
| Injections, Intralesional | 1 | 2017 | 47 | 0.030 |
Why?
|
| Intervertebral Disc | 1 | 2017 | 14 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2018 | 166 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 557 | 0.030 |
Why?
|
| Neoplasms, Second Primary | 1 | 2019 | 149 | 0.030 |
Why?
|
| Postmenopause | 1 | 2017 | 153 | 0.030 |
Why?
|
| Headache | 1 | 2017 | 110 | 0.030 |
Why?
|
| Water | 1 | 2017 | 195 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2016 | 202 | 0.030 |
Why?
|
| Polymers | 1 | 2016 | 108 | 0.030 |
Why?
|
| Cell Engineering | 1 | 2015 | 20 | 0.030 |
Why?
|
| Transcription Factor HES-1 | 1 | 2015 | 18 | 0.030 |
Why?
|
| Lewis X Antigen | 1 | 2015 | 11 | 0.030 |
Why?
|
| CD24 Antigen | 1 | 2015 | 33 | 0.030 |
Why?
|
| Dipeptides | 1 | 2015 | 65 | 0.030 |
Why?
|
| Receptor, Notch1 | 1 | 2015 | 76 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2017 | 504 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2015 | 198 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 363 | 0.030 |
Why?
|
| Orthopedic Procedures | 1 | 2014 | 74 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2013 | 140 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 820 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2017 | 1233 | 0.020 |
Why?
|
| Patient Safety | 1 | 2017 | 439 | 0.020 |
Why?
|
| Urinary Bladder Diseases | 1 | 2012 | 34 | 0.020 |
Why?
|
| Survival | 1 | 2012 | 18 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 373 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 2012 | 107 | 0.020 |
Why?
|
| Intracranial Hemorrhages | 1 | 2012 | 81 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2016 | 1440 | 0.020 |
Why?
|
| Glasgow Coma Scale | 1 | 2012 | 200 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2012 | 70 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 2012 | 111 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 574 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 897 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2012 | 118 | 0.020 |
Why?
|
| Models, Biological | 1 | 2016 | 1443 | 0.020 |
Why?
|
| Proteins | 1 | 2016 | 1035 | 0.020 |
Why?
|
| Adolescent | 3 | 2013 | 20535 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2013 | 506 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 852 | 0.020 |
Why?
|
| United States | 1 | 2025 | 11648 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 1351 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 3037 | 0.020 |
Why?
|
| Brain Injuries | 1 | 2012 | 716 | 0.020 |
Why?
|
| Seizures | 1 | 2012 | 893 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 1378 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2015 | 4703 | 0.010 |
Why?
|
| Infant | 1 | 2014 | 13047 | 0.010 |
Why?
|
| Child | 1 | 2012 | 25761 | 0.010 |
Why?
|